Skip to content

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality in Patients with Insomnia Disorder

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality in Patients with Insomnia Disorder: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125912
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Disorder

Interventions

Intervention Group:Percutaneous ear vagus nerve sham stimulation group

Sponsors

Hefei Cancer Hospital,Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18–70 years with insomnia disorder, regardless of gender. 2.Meets the diagnostic criteria of ICSD-3 and DSM-5 for insomnia disorder. 3.A Pittsburgh Sleep Quality Index (PSQI) total score > 8, with clinically significant sleep quality impairment. 4.Be capable of understanding and cooperating in scale evaluations and home interventions, and voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with severe mental disorders, cardiovascular and cerebrovascular diseases, or other severe physical illnesses. 2.Individuals implanted with electronic devices such as cardiac pacemakers. 3.Females during pregnancy or lactation period 4.Patients with ear diseases, malformations or skin damage that preclude electrode placement. 5.Insomnia caused by objective factors (untreated internal diseases, mental disorders) or substance-related factors (including but not limited to caffeine, alcohol, tobacco, etc.). 6.Patients diagnosed with other types of sleep disorders besides insomnia disorder. 7.Those who are currently using, or have used within 2 weeks before enrollment, medications that may significantly affect sleep architecture and neuroelectrophysiological activities.

Design outcomes

Primary

MeasureTime frame
Sleep quality;

Secondary

MeasureTime frame
24-hour average systolic/diastolic blood pressure;Emotional indicators;Quality of Life;Circadian blood pressure decline rate;

Countries

China

Contacts

Public ContactDengdeng Feng

Department of Internal Medicine, Hefei Cancer Hospital,Chinese Academy of Sciences

2206089510@qq.com+86 152 5693 9570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026